Immunology and Pathobiology of Plasma Cell Disorders
Conditions
Plasma cell disorder
Trial Phase
Trial Purpose and Description
Trial Purpose
Participation Guidelines
- Age:
- 18 and older
- Gender:
- Both
Eligibility Criteria
- Sponsor:
- Dana Foundation, Inc
- Leukemia and Lymphoma Society
- National Cancer Institute (NCI)
- NIH
- Dates:
- September 2008
- Last Updated:
- Study HIC#:
- 0803003627
Clinicaltrials.gov ID: Yale1373363
